MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Reversible progressive supranuclear palsy-mimic induced by risperidone

H.J. Kim, J.H. Lee (Seoul, Republic of Korea)

Meeting: 2017 International Congress

Abstract Number: 422

Keywords: Drug-induced parkinsonism(DIP), Progressive supranuclear palsy(PSP)

Session Information

Date: Tuesday, June 6, 2017

Session Title: Drug-Induced Movement Disorders

Session Time: 1:45pm-3:15pm

Location: Exhibit Hall C

Objective: To report a patient who presented with a progressive supranuclear palsy (PSP)-like syndrome while receiving risperidone that disappeared after drug withdrawal.

Background: Drugs that either block dopamine receptors or deplete dopamine storage produce a functional dopaminergic deficient state, and hence cause clinical symptoms that mimic Parkinson’s disease (PD). However, these drugs rarely cause PSP-like features.

Methods: Case report

Results: A 65-year-old man was admitted because of progressive gait disturbance and falls. Three month before admission, he had developed left subdural hygroma after slipping. Drainage under a closed system was performed through burr holes by neurosurgeon. After operation, however, he developed aggressive behavior despite of resolution of subdural hygroma on follow-up brain CT scans. He was treated with risperidone for behavior symptoms. Two weeks after taking risperidone, gait disturbance and falls appeared over two-week period. On examination, he had mild dysarthria, masked face, bradykinesia, rigidity, left hand and both foot tremor, and short step gait with prominent postural instability. Ocular examination revealed both eye conjugate vertical gaze palsy, and left eye lateral and right eye medial gaze palsy, but intact vestibuloocular reflex. Videonystagmography (VNG) also showed vertical and horizontal gaze palsy.

We discontinued risperidone because it can induce extrapyramidal symptoms including parkinsonism. After one month, he gradually improved and was able to walk without assistance. Follow-up VNG did not show supranuclear gaze palsy.

Conclusions: This is a case of a PSP-like syndrome occurring in association with administration of an atypical antipsychotic drug and disappearing after medication withdrawal. This case emphasizes the importance of considering atypical antipsychotics as a possible cause of atypical parkinsonism with rapid or subacute onset and shows that immediate withdrawal of these drugs may reverse the symptoms.

To cite this abstract in AMA style:

H.J. Kim, J.H. Lee. Reversible progressive supranuclear palsy-mimic induced by risperidone [abstract]. Mov Disord. 2017; 32 (suppl 2). https://www.mdsabstracts.org/abstract/reversible-progressive-supranuclear-palsy-mimic-induced-by-risperidone/. Accessed June 14, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/reversible-progressive-supranuclear-palsy-mimic-induced-by-risperidone/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley